Personalized Disease Management
 
 
We understand that every patient is unique and individualized treatment is desirable. We strive to help physicians improve diagnostic accuracy and to optimize your patients’ disease management through personalized therapy. Our passion is to contribute to the understanding of the disease and the somatic responses to it, and in slowing and ultimately preventing the progression of Multiple Sclerosis and its associated disabilities.

To address the unmet needs of the MS treating and patient community, Glycominds offers diagnostic and prognostic tests that can contribute additional information to help guide treatment decisions for patients with Multiple Sclerosis.
 
 
News & Events
New Results to be Presented at ECTRIMS & ACTRIMS, 2011
Come see us at The 5th Joint Triennial Congress of ECTRIMS and ACTRIMS!
We will be Presenting in Poster Topic Biomarker 2, Poster Number P1091

Where: Amsterdam, Congress Venue - Amsterdam RAI Congress and Conference Centre

When: October 19 - 22

On Friday, from 15:30 to 17:00, October 21st, 2011, We will be Presenting in Poster Topic Biomarker 2, Poster Number P1091:

gMS-Classifier2 serum assay as a potential predictor of early conversion to Clinically Definite Multiple Sclerosis in patients with a clinically isolated syndrome


Blood tests for Multiple Sclerosis
www.gms.net
IVD kits for individualized risk assessment of complicated Crohn's Disease patients
www.ibdx.net
Site Map | Privacy Policy | Contact Us
© 2011 Glycominds Ltd. All Right Reserved